tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (CLVLF)
:CLVLF
US Market

Clinuvel Pharmaceuticals (CLVLF) Income Statement

Compare
44 Followers

Clinuvel Pharmaceuticals Income Statement

Last quarter (Q4 2025), Clinuvel Pharmaceuticals 's total revenue was AU$59.37M, an increase of 21.25% from the same quarter last year. In Q4, Clinuvel Pharmaceuticals 's net income was AU$22.10M. See Clinuvel Pharmaceuticals ’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 95.02MAU$ 88.18MAU$ 78.32MAU$ 65.72MAU$ 47.98M
Gross Profit
AU$ 79.14MAU$ 80.45MAU$ 50.59MAU$ 46.62MAU$ 35.20M
Operating Expenses
AU$ 33.40MAU$ 31.30MAU$ 9.68MAU$ 13.53MAU$ 8.51M
Depreciation and Amortization
AU$ 1.18MAU$ 1.14MAU$ 789.41KAU$ 757.83KAU$ 861.43K
EBITDA
AU$ 57.20MAU$ 56.28MAU$ 46.37MAU$ 35.08MAU$ 28.19M
Operating Income
AU$ 45.73MAU$ 48.01MAU$ 40.91MAU$ 33.08MAU$ 26.70M
Other Income/Expenses
AU$ 5.82MAU$ 2.67MAU$ 1.48MAU$ -1.77MAU$ -983.49K
Pretax Income
AU$ 51.55MAU$ 50.68MAU$ 45.58MAU$ 34.32MAU$ 25.71M
Net Income
AU$ 36.17MAU$ 35.64MAU$ 30.60MAU$ 20.88MAU$ 24.73M
Per Share Metrics
Basic EPS
AU$ 0.72AU$ 0.72AU$ 0.62AU$ 0.42AU$ 0.50
Diluted EPS
AU$ 0.72AU$ 0.70AU$ 0.59AU$ 0.40AU$ 0.48
Weighted Average Shares Outstanding
50.08M 51.05M 49.41M 49.41M 49.41M
Weighted Average Shares Outstanding (Diluted)
50.38M 51.03M 51.82M 51.78M 51.13M
Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History